2024
Effect of upper eyelid blepharoplasty on the ocular surface, tear film, and corneal microstructure
Aygun O, Arat Y, Dikmetas O, Karakaya J, Baytaroglu A, Irkec M. Effect of upper eyelid blepharoplasty on the ocular surface, tear film, and corneal microstructure. Arquivos Brasileiros De Oftalmologia 2024, 87: e2022-0220. PMID: 38537039, PMCID: PMC11627281, DOI: 10.5935/0004-2749.2022-0220.Peer-Reviewed Original ResearchConceptsUpper eyelid blepharoplastyEyelid blepharoplastyOcular surfaceTear filmIn vivo confocal microscopy parametersOcular Surface Disease Index questionnaireStrip of orbicularis oculi muscleTear film breakup time measurementsTear film breakup timeOcular Surface Disease IndexIn vivo confocal microscopyDry eye-related symptomsConfocal microscopy parametersLissamine green stainingOcular surface stainingFilm breakup timeSurface Disease IndexDry eye symptomsSchirmer test scoresTear film stabilityEye-related symptomsOrbicularis oculi muscleCorneal fluoresceinCorneal microstructureSchirmer test
2023
Chapter 29 The aging eye and age-related ocular pathologies
Arat Y. Chapter 29 The aging eye and age-related ocular pathologies. 2023, 319-338. DOI: 10.1016/b978-0-323-98804-9.00001-3.Peer-Reviewed Original ResearchEye diseaseAge-related ocular pathologiesAge-related macular degenerationSight-threatening eye diseaseDry eye diseaseAge-related pathogenesisOcular surfaceMacular degenerationOcular pathologyAging eyeClinical findingsOphthalmic diseasesAge-relatedAge-related diseasesFunctional changesDiseaseEyesPathologyAgeGlaucomaIncreased vulnerabilityCataractPathogenesisRetinaLate life
2019
Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma
Kim JM, Weiss S, Sinard JH, Pointdujour-Lim R. Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma. Ocular Oncology And Pathology 2019, 6: 35-38. PMID: 32002403, PMCID: PMC6984155, DOI: 10.1159/000497473.Peer-Reviewed Original ResearchMinimally Invasive Corneal Neurotization With Acellular Nerve Allograft
Leyngold I, Yen M, Tian J, Leyngold M, Vora G, Weller C. Minimally Invasive Corneal Neurotization With Acellular Nerve Allograft. Ophthalmic Plastic And Reconstructive Surgery 2019, Publish Ahead of Print: &na;. PMID: 30059392, DOI: 10.1097/iop.0000000000001181.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAllograftsChildCorneaCorneal DiseasesFemaleFollow-Up StudiesHumansMaleMicroscopy, ConfocalMiddle AgedMinimally Invasive Surgical ProceduresNerve RegenerationNerve TransferOphthalmic NerveOphthalmologic Surgical ProceduresRetrospective StudiesTreatment OutcomeYoung AdultConceptsAcellular nerve allograftsNerve allograftsCorneal neurotizationCorneal sensibilityVivo confocal microscopyInvasive surgical techniquesCorneal epithelial integrityNeurotrophic keratopathyAffected eyeNerve densityClinical outcomesInfraorbital nerveVisual acuityNerve pediclesSurgical techniqueInvasive approachOcular surfaceRetrospective evaluationAllograftsTransconjunctival approachCorneal stromaNeurotizationPatientsEpithelial integrityMonths
2016
Ocular Manifestations of Inherited Phospholipase-C&ggr;2–Associated Antibody Deficiency and Immune Dysregulation
Di Zazzo A, Tahvildari M, Florakis G, Dana R. Ocular Manifestations of Inherited Phospholipase-C&ggr;2–Associated Antibody Deficiency and Immune Dysregulation. Cornea 2016, 35: 1656-1657. PMID: 27442322, PMCID: PMC5250612, DOI: 10.1097/ico.0000000000000951.Peer-Reviewed Original ResearchConceptsOcular manifestationsOcular surfaceAntibody deficiencyImmune dysregulationEpisodes of ocular inflammationInterleukin-1Anti-IL-1 therapySystemic immunomodulatory treatmentSystemic side effectsBouts of inflammationInterstitial lung diseaseRecurrent inflammatory diseaseInterleukin-1 productionCorneal pannusCorneal involvementCorneal scarringOcular inflammationOral prednisoneOcular symptomsSystemic immunosuppressionImmunomodulatory treatmentSystemic manifestationsLung diseaseActive lesionsPartial improvementCyclosporine for Dry Eye Associated With Nivolumab
Nguyen AT, Elia M, Materin MA, Sznol M, Chow J. Cyclosporine for Dry Eye Associated With Nivolumab. Cornea 2016, 35: 399-401. PMID: 26771550, DOI: 10.1097/ico.0000000000000724.Peer-Reviewed Original ResearchConceptsDry eye diseaseMetastatic melanomaTopical cyclosporineCorneal perforationDry eyeEye diseaseSevere dry eye symptomsBilateral dry eyesDry Eye AssociatedOcular surface inflammationSevere dry eyeDry eye symptomsImprovement of symptomsNivolumab therapyIntensive regimenSurface inflammationEye symptomsMetastatic diseaseClinical outcomesAggressive lubricationRight eyeCase reportNivolumabOcular surfaceAntitumor effects
2009
Antioxidant Defenses in the ocular surface
Chen Y, Mehta G, Vasiliou V. Antioxidant Defenses in the ocular surface. The Ocular Surface 2009, 7: 176-185. PMID: 19948101, PMCID: PMC4104792, DOI: 10.1016/s1542-0124(12)70185-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply